Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES - SCHEDULE OF ACCRUED EXPENSES (Details)

v3.24.3
ACCRUED EXPENSES - SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accrued pre-clinical and clinical costs $ 1,628 $ 1,449
Accrued product development costs 1,671 745
Accrued license costs 1,625 4,825
Accrued compensation 1,823 2,326
Accrued administrative costs 429 343
Accrued interest 0 1,342
Total $ 7,176 $ 11,030